Macrophagic myofasciitis: Inflammatory, vaccination-associated muscular disease;Makrophagische Myofasziitis: Eine Impfungs-assoziierte entzündliche Muskelerkrankung

Deutsche Medizinische Wochenschrift

Volumn 128, Issue 44, 2003, Pages 2305-2308

  Fischer, D ^a   Reimann, J ^a   Schroder R ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ALUMINUM HYDROXIDE; ANTIBODY; AZATHIOPRINE; CREATINE KINASE; STEROID; TETANUS TOXOID;

AGED; ANTIBODY TITER; ARTICLE; CASE REPORT; CELL INFILTRATION; DELTOID MUSCLE; ELECTROMYOGRAM; ELECTRON MICROSCOPY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; LABORATORY TEST; MACROPHAGE; MACROPHAGIC MYOFASCIITIS; MALE; MUSCLE BIOPSY; MUSCLE DISEASE; MUSCLE WEAKNESS; MYALGIA; NEUROLOGIC EXAMINATION; PERIODIC ACID SCHIFF STAIN; SEROLOGY; STEROID THERAPY; TETANUS PROPHYLAXIS;

ADRENAL CORTEX HORMONES; AGED; AZATHIOPRINE; BIOPSY; ELECTROMYOGRAPHY; FASCIITIS; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAMUSCULAR; MACROPHAGES; MALE; MUSCLES; MYOSITIS; TETANUS TOXOID; TIME FACTORS; VACCINATION;

EID: 0242659269     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-43184     Document Type: Article

References (10)

1. Authier FJ, Cherin P, Creange A et al. Central nervous system disease in patients with macrophagic myofasciitis. Brain 2001; 124: 974-983
2. Authier FJ, Sauvat S, Champey J, Drogou I, Coquet M, Gherardi RK. Chronic fatigue syndrome in patients with macrophagic myofasciitis. Arthritis Rheum 2003; 48: 569-570
3. Brewer JM, Conacher M, Hunter CA, Mohrs M, Brombacher F, Alexander J. Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4-or IL-13-mediated signaling. J Immunol 1999; 163: 6448-6454
4. Flarend RE, Hem SL, White JL et al. In vivo absorption of aluminium-containing vaccine adjuvants using 26Al. Vaccine 1997; 15: 1314-1318
5. Gherardi RK, Coquet M, Cherin P et al. Macrophagic myofasciitis: an emerging entity. Groupe d'Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l'Association Francaise contre les Myopathies (AFM). Lancet 1998; 352: 347-352
6. Gherardi RK, Coquet M, Cherin P et al. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 2001; 124: 1821-1831
7. Hassan IS, Bannister BA, Akbar A, Weir W, Bofill M. A study of the immunology of the chronic fatigue syndrome: correlation of immunologic parameters to health dysfunction. Clin Immunol Immunopathol 1998; 87: 60-67
8. Rook GA, Zumla A. Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile? Lancet 1997; 349: 1831-1833
9. Ulanova M, Tarkowski A, Hahn-Zoric M, Hanson LA. The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism. Infect Immun 2001; 69: 1151-1159
10. WHO VSAC. Makrophagic myofasciitis and aluminium-containing vaccines. Wkly Epidemiol Rec 1999; 74: 338-340